U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088484) titled 'Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma' on July 20.
Brief Summary: The purpose of this study is to compare chemotherapy plus immunotherapy with immunochemotherapy combined subsequent locoregional radiotherapy in recurrent nasopharyngeal carcinoma (NPC), in order to confirm the value of immunotherapy and chemotherapy in recurrent NPC patients.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
Recurrent Nasopharyngeal Carcinoma
Intervention:
DRUG: ICI-chemotherapy and LIMT
gemcitabine, docetaxel, paclitaxel, cisplatin, platinum, capecitabine, S1; Tislelizumab.
Recruit...